HCA Healthcare UK has delivered its first Tumour-Infiltrating Lymphocyte (TIL) therapy for a...
Category - Medical Devices & Diagnostics
Koselugo Recommended for EU Approval in Adults with NF1...
AstraZeneca’s Koselugo (selumetinib) has secured a positive recommendation from the European...
SAR446268 Earns US Fast Track Designation for Non-Congenital...
Sanofi is pleased to announce that the US Food and Drug Administration (FDA) has granted Fast Track...
Enhertu plus pertuzumab granted FDA Priority Review as potential...
AstraZeneca and Daiichi Sankyo have announced that the US Food and Drug Administration (FDA) has...
Johnson & Johnson Reports Positive Phase 3 Results for...
Johnson & Johnson has released new Phase 3 clinical trial data showing that icotrokinra, a...
Sanofi’s Brivekimig Shows Positive Phase 2a Results in...
Sanofi has reported encouraging Phase 2a data for brivekimig, a dual-target Nanobody® molecule...
Novartis to Acquire Tourmaline Bio, Expanding Cardiovascular...
Novartis has announced plans to acquire Tourmaline Bio, strengthening its cardiovascular pipeline...
Sanofi Gene Therapy Gains FDA Fast Track Designation for Wet Age...
Sanofi has announced that the US Food and Drug Administration (FDA) has granted Fast Track...
Roche Receives CE Mark for Contivue Port Delivery Platform in...
Roche has announced that the European Union has granted CE Mark approval for Contivue®, its Port...
Trinity Biotech Reports Breakthrough Clinical Trial Results for...
Trinity Biotech has announced positive clinical trial results for its newly redesigned continuous...